As NLRX1 seems to be downregulated in the heart from acute myocardial infarction (AMI) (9), the activation of NLRX1 by novel compounds (34) may offer new therapeutic option to protect patients from myocardial infarction. The gene discussed is NLRX1; the disease is myocardial infarction.